X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1632) 1632
Publication (123) 123
Patent (39) 39
Book Chapter (19) 19
Book / eBook (5) 5
Book Review (5) 5
Newsletter (3) 3
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (917) 917
risk factors (540) 540
female (532) 532
middle aged (486) 486
male (410) 410
aged (318) 318
cardiac & cardiovascular systems (312) 312
c-reactive protein (300) 300
risk (270) 270
inflammation (263) 263
cardiovascular disease (228) 228
peripheral vascular disease (213) 213
prospective studies (212) 212
cardiovascular-disease (204) 204
cholesterol (199) 199
adult (197) 197
women (192) 192
medicine, general & internal (184) 184
health aspects (182) 182
atherosclerosis (180) 180
medicin och hälsovetenskap (178) 178
medical and health sciences (176) 176
prevention (174) 174
abridged index medicus (168) 168
cardiovascular diseases (168) 168
coronary-heart-disease (162) 162
research (162) 162
primary prevention (158) 158
genetics (150) 150
biomarkers - blood (149) 149
myocardial-infarction (142) 142
polymorphism, single nucleotide (137) 137
genome-wide association study (135) 135
c-reactive protein - analysis (130) 130
c-reactive protein - metabolism (127) 127
disease (127) 127
cohort studies (124) 124
statins (123) 123
case-control studies (118) 118
genetics & heredity (116) 116
mortality (115) 115
cardiovascular diseases - prevention & control (114) 114
epidemiology (112) 112
genotype (111) 111
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (111) 111
genetic aspects (105) 105
womens health (105) 105
lipids (104) 104
studies (102) 102
aged, 80 and over (101) 101
hematology (99) 99
risk assessment (99) 99
heart attacks (98) 98
follow-up studies (97) 97
genome-wide association (97) 97
stroke (97) 97
incidence (96) 96
body mass index (95) 95
genomes (94) 94
cardiovascular diseases - epidemiology (93) 93
clinical medicine (93) 93
blood pressure (92) 92
association (90) 90
double-blind method (86) 86
genetic predisposition to disease (86) 86
meta-analysis (86) 86
klinisk medicin (84) 84
myocardial infarction (84) 84
cardiovascular diseases - blood (83) 83
proteins (83) 83
cholesterol, ldl - blood (82) 82
metaanalysis (82) 82
men (79) 79
randomized controlled trials as topic (78) 78
biomarkers (75) 75
health risk assessment (74) 74
hypertension (72) 72
predictive value of tests (72) 72
statin therapy (72) 72
cardiovascular (71) 71
medical research (71) 71
medicinsk genetik (70) 70
analysis (69) 69
diabetes (69) 69
events (69) 69
lipoproteins (69) 69
medical genetics (69) 69
clinical trials (68) 68
physiological aspects (67) 67
proportional hazards models (67) 67
loci (66) 66
genetic variation (63) 63
medicinska och farmaceutiska grundvetenskaper (63) 63
basic medicine (62) 62
risk-factors (62) 62
heart attack (61) 61
united states - epidemiology (61) 61
treatment outcome (60) 60
genomics (59) 59
cholesterol, hdl - blood (58) 58
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1825) 1825
French (17) 17
German (7) 7
Danish (1) 1
Japanese (1) 1
Norwegian (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Estrada, Karol and Styrkarsdottir, Unnur and Evangelou, Evangelos and Hsu, Yi-Hsiang and Duncan, Emma L and Ntzani, Evangelia E and Oei, Ling and Albagha, Omar M E and Amin, Najaf and Kemp, John P and Koller, Daniel L and Li, Guo and Liu, Ching-Ti and Minster, Ryan L and Moayyeri, Alireza and Vandenput, Liesbeth and Willner, Dana and Xiao, Su-Mei and Yerges-Armstrong, Laura M and Zheng, Hou-Feng and Alonso, Nerea and Eriksson, Joel and Kammerer, Candace M and Kaptoge, Stephen K and Leo, Paul J and Thorleifsson, Gudmar and Wilson, Scott G and Wilson, James F and Aalto, Ville and Alen, Markku and Aragaki, Aaron K and Aspelund, Thor and Center, Jacqueline R and Dailiana, Zoe and Duggan, David J and Garcia, Melissa and Garcia-Giralt, Natàlia and Giroux, Sylvie and Hallmans, Göran and Hocking, Lynne J and Husted, Lise Bjerre and Jameson, Karen A and Khusainova, Rita and Kim, Ghi Su and Kooperberg, Charles and Koromila, Theodora and Kruk, Marcin and Laaksonen, Marika and Lacroix, Andrea Z and Lee, Seung Hun and Leung, Ping C and Lewis, Joshua R and Masi, Laura and Mencej-Bedrac, Simona and Nguyen, Tuan V and Nogues, Xavier and Patel, Millan S and Prezelj, Janez and Rose, Lynda M and Scollen, Serena and Siggeirsdottir, Kristin and Smith, Albert V and Svensson, Olle and Trompet, Stella and Trummer, Olivia and van Schoor, Natasja M and Woo, Jean and Zhu, Kun and Balcells, Susana and Brandi, Maria Luisa and Buckley, Brendan M and Cheng, Sulin and Christiansen, Claus and Cooper, Cyrus and Dedoussis, George and Ford, Ian and Frost, Morten and Goltzman, David and González-Macías, Jesús and Kähönen, Mika and Karlsson, Magnus and Khusnutdinova, Elza and Koh, Jung-Min and Kollia, Panagoula and Langdahl, Bente Lomholt and Leslie, William D and Lips, Paul and Ljunggren, Östen and Lorenc, Roman S and Marc, Janja and Mellström, Dan and Obermayer-Pietsch, Barbara and Olmos, José M and Pettersson-Kymmer, Ulrika and Reid, David M and Riancho, José A and Ridker, Paul M and Rousseau, François and lagboom, P Eline S and Tang, Nelson L S and ... and Centre for Bone and Arthritis Research and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Nature genetics, ISSN 1546-1718, 2012, Volume 44, Issue 5, pp. 491 - 501
textabstractBone mineral density (BMD) is the most widely used predictor of fracture risk. We performed the largest meta-analysis to date on lumbar spine and... 
WOMEN | GENE | VARIANTS | DISEASE | GENETICS & HEREDITY | OSTEOPOROTIC FRACTURES | LRP5 | PATTERNS | EXPRESSION | BURDEN | HIP | Glycoproteins - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Low Density Lipoprotein Receptor-Related Protein-5 - genetics | Extracellular Matrix Proteins - genetics | Humans | Risk Factors | Computational Biology | Intercellular Signaling Peptides and Proteins - genetics | European Continental Ancestry Group | Genotype | Male | Bone Density - genetics | Gene Expression Profiling | Phosphoproteins - genetics | Fractures, Bone - genetics | Mitochondrial Membrane Transport Proteins - genetics | Polymorphism, Single Nucleotide - genetics | Female | Femur Neck - physiopathology | Osteoporosis - genetics | Spectrin - genetics | Quantitative Trait Loci | Lumbar Vertebrae - physiopathology | Quantitative trait loci | Measurement | Fractures | Bones | Genetic aspects | Identification and classification | Density | Risk factors | Medical research | Osteoporosis | Genomics | Bone density | Gene loci | Vèrtebres lumbars | Gens | Femur | Genes | Bone densitometry | Densitometria òssia | Fèmur | Lumbar vertebrae | Spectrin | Klinisk medicin | Single Nucleotide | Mitochondrial Membrane Transport Proteins | genetics | Endokrinologi och diabetes | Extracellular Matrix Proteins | Phosphoproteins | Endocrinology and Diabetes | Bone Density | Low Density Lipoprotein Receptor-Related Protein-5 | Intercellular Signaling Peptides and Proteins | Femur Neck | Glycoproteins | Clinical Medicine | physiopathology | Bone | Lumbar Vertebrae | Polymorphism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 21, pp. 2195 - 2207
In this trial, 17,802 healthy men and women with low-density lipoprotein cholesterol levels of less than 130 mg per deciliter and high-sensitivity C-reactive... 
TRIALS | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | INFLAMMATION | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | RISK | PRAVASTATIN | CORONARY-HEART-DISEASE | PREDICTION | Myocardial Infarction - epidemiology | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | C-Reactive Protein - metabolism | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Stroke - epidemiology | Muscular Diseases - chemically induced | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Rosuvastatin Calcium | Biomarkers - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Diabetes Mellitus - chemically induced | Aged | Fluorobenzenes - adverse effects | Myocardial Infarction - prevention & control | Fluorobenzenes - therapeutic use | Prevention | Usage | C-reactive protein | Rosuvastatin | Cardiovascular diseases | Drug therapy | Health aspects | Proteins | Cardiovascular disease | Heart attacks | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
by Joshi, Peter K and Pirastu, Nicola and Kentistou, Katherine A and Fischer, Krista and Hofer, Edith and Schraut, Katharina E and Clark, David W and Nutile, Teresa and Barnes, Catriona L. K and Timmers, Paul R. H. J and Shen, Xia and Gandin, Ilaria and McDaid, Aaron F and Hansen, Thomas Folkmann and Gordon, Scott D and Giulianini, Franco and Boutin, Thibaud S and Abdellaoui, Abdel and Zhao, Wei and Medina-Gomez, Carolina and Bartz, Traci M and Trompet, Stella and Lange, Leslie A and Raffield, Laura and van der Spek, Ashley and Galesloot, Tessel E and Proitsi, Petroula and Yanek, Lisa R and Bielak, Lawrence F and Payton, Antony and Murgia, Federico and Concas, Maria Pina and Biino, Ginevra and Tajuddin, Salman M and Seppälä, Ilkka and Amin, Najaf and Boerwinkle, Eric and Børglum, Anders D and Campbell, Archie and Demerath, Ellen W and Demuth, Ilja and Faul, Jessica D and Ford, Ian and Gialluisi, Alessandro and Gögele, Martin and Graff, MariaElisa and Hingorani, Aroon and Hottenga, Jouke-Jan and Hougaard, David M and Hurme, Mikko A and Ikram, M. Arfan and Jylhä, Marja and Kuh, Diana and Ligthart, Lannie and Lill, Christina M and Lindenberger, Ulman and Lumley, Thomas and Mägi, Reedik and Marques-Vidal, Pedro and Medland, Sarah E and Milani, Lili and Nagy, Reka and Ollier, William E. R and Peyser, Patricia A and Pramstaller, Peter P and Ridker, Paul M and Rivadeneira, Fernando and Ruggiero, Daniela and Saba, Yasaman and Schmidt, Reinhold and Schmidt, Helena and Slagboom, P. Eline and Smith, Blair H and Smith, Jennifer A and Sotoodehnia, Nona and Steinhagen-Thiessen, Elisabeth and van Rooij, Frank J. A and Verbeek, André L and Vermeulen, Sita H and Vollenweider, Peter and Wang, Yunpeng and Werge, Thomas and Whitfield, John B and Zonderman, Alan B and Lehtimäki, Terho and Evans, Michele K and Pirastu, Mario and Fuchsberger, Christian and Bertram, Lars and Pendleton, Neil and Kardia, Sharon L. R and Ciullo, Marina and Becker, Diane M and Wong, Andrew and Psaty, Bruce M and van Duijn, Cornelia M and Wilson, James G and Jukema, J. Wouter and Kiemeney, Lambertus and Uitterlinden, André G and ...
Nature communications, ISSN 2041-1723, 2017, Volume 8, Issue 1, pp. 910 - 13
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
by Zheng, Hou‐Feng and Forgetta, Vincenzo and Hsu, Yi‐Hsiang and Estrada, Karol and Rosello‐Diez, Alberto and Leo, Paul J and Dahia, Chitra L and Park‐Min, Kyung Hyun and Tobias, Jonathan H and Kooperberg, Charles and Kleinman, Aaron and Styrkarsdottir, Unnur and Liu, Ching‐Ti and Uggla, Charlotta and Evans, Daniel S and Nielson, Carrie M and Walter, Klaudia and Pettersson‐Kymmer, Ulrika and McCarthy, Shane and Eriksson, Joel and Kwan, Tony and Jhamai, Mila and Trajanoska, Katerina and Memari, Yasin and Min, Josine and Huang, Jie and Danecek, Petr and Wilmot, Beth and Li, Rui and Chou, Wen‐Chi and Mokry, Lauren E and Moayyeri, Alireza and Claussnitzer, Melina and Cheng, Chia‐Ho and Cheung, Warren and Medina‐Gómez, Carolina and Ge, Bing and Chen, Shu‐Huang and Choi, Kwangbom and Oei, Ling and Fraser, James and Kraaij, Robert and Hibbs, Matthew A and Gregson, Celia L and Paquette, Denis and Hofman, Albert and Wibom, Carl and Tranah, Gregory J and Marshall, Mhairi and Gardiner, Brooke B and Cremin, Katie and Auer, Paul and Hsu, Li and Ring, Sue and Tung, Joyce Y and Thorleifsson, Gudmar and Enneman, Anke W and van Schoor, Natasja M and de Groot, Lisette C. P. G. M and van der Velde, Nathalie and Melin, Beatrice and Kemp, John P and Christiansen, Claus and Sayers, Adrian and Zhou, Yanhua and Calderari, Sophie and van Rooij, Jeroen and Carlson, Chris and Peters, Ulrike and Berlivet, Soizik and Dostie, Josée and Uitterlinden, Andre G and Williams, Stephen R and Farber, Charles and Grinberg, Daniel and LaCroix, Andrea Z and Haessler, Jeff and Chasman, Daniel I and Giulianini, Franco and Rose, Lynda M and Ridker, Paul M and Eisman, John A and Nguyen, Tuan V and Center, Jacqueline R and Nogues, Xavier and Garcia‐Giralt, Natalia and Launer, Lenore L and Gudnason, Vilmunder and Mellström, Dan and Vandenput, Liesbeth and Amin, Najaf and van Duijn, Cornelia M and Karlsson, Magnus K and Ljunggren, Östen and Svensson, Olle and Hallmans, Göran and Rousseau, François and Giroux, Sylvie and Bussière, Johanne and Arp, Pascal P and ... and AOGC Consortium and UK10K Consortium and Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa and Göteborgs universitet and Gothenburg University and Institute of Medicine, School of Public Health and Community Medicine and Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition and Sahlgrenska Academy and Centre for Bone and Arthritis Research and Sahlgrenska akademin and Institute of Medicine, Department of Internal Medicine and Clinical Nutrition
Nature (London), ISSN 1476-4687, 2015, Volume 526, Issue 7571, pp. 112 - 117
Journal Article